Sprifermin, Recombinant human fibroblast growth factor 18 (rhFGF18)

Specification

• Cat#: THP-0305
• Product Name: Sprifermin, Recombinant human fibroblast growth factor 18 (rhFGF18)
• Cas No: 890058-52-3
• Description: Sprifermin (developmental code name AS-902330), also known as recombinant human fibroblast growth factor 18 (rhFGF18), is a recombinant form of human fibroblast growth factor 18 (FGF18). As a recombinant form of FGF18, sprifermin is a potent agonist of the FGFR2 and FGFR3.
• Species: Human
• Purity: >99% by SDS-Page and HPLC analysis
• Endotoxin: <0.1 EU per 1 μg of the peptide by the LAL method
• Application: Sprifermin has been used in trials studying the treatment of Osteoarthritis, Knee and Cartilage Injury of Knee.

Pharmaceutical Information

• Pharmaceutical Application: Sprifermin